DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Sanofi (ADR) (NYSE: SNY)

49.97 1.17 (2.40%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SNY $49.97 2.40%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.57
Previous Close $48.80
Daily Range $49.36 - $50.14
52-Week Range $43.57 - $57.42
Market Cap $131.9B
P/E Ratio 26.24
Dividend (Yield) $1.62 (2.2%)
Ex-Dividend Date
Dividend Pay Date
05/06/15
06/02/15
Volume 1,057,851
Average Daily Volume 1,529,776
Current FY EPS $3.11

Sector

Healthcare

Industry

Drug Makers

Sanofi (ADR) (SNY) Description

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Website: http://www.sanofi.com/

News & Commentary Rss Feed

Investors' Love/Hate Relationship with MannKind Corp. Stock

Emotions run high when it comes to this biotech.

European ADRs Flat as Pharma Gains Are Outweighed By Mining Losses

Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog

Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog

Is It Time for GlaxoSmithKline plc to Change Management?

GlaxoSmithKline's share price has stagnated under CEO Andrew Witty. Is it time for a change?

Isis Pharmaceuticals Reports Phase I Data on Lipid Candidate - Analyst Blog

Why It Makes Sense For Sanofi To Acquire Zoetis

Health Care Sector Update for 03/24/2015: VCEL,ABMD,CTIX

Is This The Biggest Threat to Isis Pharmaceuticals Stock?

Isis Pharmaceuticals has garnered a massive premium based on the potential of its antisense drug pipeline. With numerous companies entering the rare disease field, though, Isis' drugs might face stiff competition. So are investors being overly optimistic?

In Case You Missed It, This Tiny Biotech Is Poised for Explosive Growth

Amicus Therapeutics, Inc. plans to file its drug for Fabry disease with EU and U.S. regulators soon.

3 Biotech Stocks to Buy If the Sector Crashes

Our experts recommend Alnylam Pharmaceuticals, Celgene, and Biogen Idec.

See More SNY News...

SNY's Top Competitors

SNY $49.97 (2.40%)
Current stock: SNY
JNJ $100.34 (0.20%)
Current stock: JNJ
GSK $47.02 (0.77%)
Current stock: GSK
AZN $70.07 (0.43%)
Current stock: AZN